Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue
Public ClinicalTrials.gov record NCT03423173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Demonstrate Lot-to-Lot Consistency of 3 Lots of a Tetravalent Dengue Vaccine Candidate in Healthy Adults in Non-Endemic Country(Ies) for Dengue
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate lot-to-lot consistency in terms of equivalence of the immune responses induced by 3 consecutive TDV lots in healthy participants aged 18 to 60 years in non-endemic country(ies) for dengue.
Study identification
- NCT ID
- NCT03423173
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 923 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 11, 2018
- Primary completion
- Aug 2, 2018
- Completion
- Jan 13, 2019
- Last update posted
- Oct 19, 2020
2018 – 2019
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Optimal Research | Huntsville | Alabama | 35802 | — |
| Anaheim Clinical Trials, LLC | Anaheim | California | 92805 | — |
| Advanced Clinical Research | Boise | Idaho | 83704 | — |
| Optimal Research | Peoria | Illinois | 61614 | — |
| Synexus Limited- Council Bluffs | Council Bluffs | Iowa | 51503 | — |
| Heartland Research Associates LLC - Augusta | Augusta | Kansas | 67010 | — |
| Heartland Research Associates LLC | Park City | Kansas | 67219 | — |
| Optimal Research | Rockville | Maryland | 20850 | — |
| Synexus Limited - Minneapolis | Edina | Minnesota | 55435 | — |
| Synexus Limited - St. Louis | St Louis | Missouri | 63141 | — |
| Clinical Research Center of Nevada | Las Vegas | Nevada | 89104 | — |
| Synexus Limited - Columbus | Columbus | Ohio | 43212 | — |
| Advanced Clinical Research | Salt Lake City | Utah | 84123 | — |
| Advanced Clinical Research | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03423173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 19, 2020 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03423173 live on ClinicalTrials.gov.